|
Volumn 65, Issue 5, 2015, Pages 574-575
|
Oral combination therapy in primary care
|
Author keywords
Alpha glucosidaseinhibitors; DPP4 inhibitors; Metformin; Oral anti diabeticdrugs; Pioglitazone; Sulfonylureas
|
Indexed keywords
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
HEMOGLOBIN A1C;
METFORMIN;
ORAL ANTIDIABETIC AGENT;
PIOGLITAZONE;
SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR;
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIDIABETIC AGENT;
CANAGLIFLOZIN;
DRUG COMBINATION;
GLYCOSIDASE INHIBITOR;
SODIUM GLUCOSE COTRANSPORTER 2;
SULFONYLUREA DERIVATIVE;
ARTICLE;
DIABETES MELLITUS;
DRUG SAFETY;
DRUG TOLERANCE;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HUMAN;
HYPERGLYCEMIA;
HYPOGLYCEMIA;
INSULIN RELEASE;
INSULIN SENSITIVITY;
PATIENT SATISFACTION;
PRIMARY MEDICAL CARE;
WEIGHT GAIN;
ANTAGONISTS AND INHIBITORS;
DIABETES MELLITUS, TYPE 2;
DRUG COMBINATION;
PRIMARY HEALTH CARE;
CANAGLIFLOZIN;
DIABETES MELLITUS, TYPE 2;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
DRUG COMBINATIONS;
DRUG THERAPY, COMBINATION;
GLYCOSIDE HYDROLASE INHIBITORS;
HUMANS;
HYPOGLYCEMIC AGENTS;
METFORMIN;
PRIMARY HEALTH CARE;
SODIUM-GLUCOSE TRANSPORTER 2;
SULFONYLUREA COMPOUNDS;
THIAZOLIDINEDIONES;
|
EID: 84930691513
PISSN: 00309982
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (4)
|